Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast Cancer

NCT00146562 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

135

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Stage I Breast Cancer
Stage II Breast Cancer

Interventions

DRUG: Darbepoetin Alfa
DRUG: Pegfilgrastim
DRUG: Paclitaxel
DRUG: Doxorubicin
DRUG: Cyclophosphamide

Sponsor

Harold J. Burstein, MD, PhD

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]